Meghmani Organics Q4 FY26 Revenue Down 9% to ₹456.6 Cr, FY26 EBITDA Up 27%
Meghmani Organics Limited reported Q4 FY26 revenue of ₹456.6 crore, down 9% YoY. FY26 revenue rose 4% to ₹2,091.8 crore. FY26 EBITDA surged 27% to ₹228.7 crore. The company added three new nano fertilizer products and temporarily suspended TiO2 operations.
The impact is considered medium due to the mixed financial results. While the full-year performance shows growth, the sharp decline in the current quarter's revenue and profitability, along with the suspension of TiO2 operations, suggests a near-term challenge for the company.
The negative sentiment is driven by the significant year-on-year decline in Q4 FY26 revenue and EBITDA, impacted by macroeconomic uncertainties and rising input costs. Although FY26 showed growth, the quarterly performance indicates ongoing challenges.
Meghmani Organics Limited (MOL) has announced its financial results for the fourth quarter and financial year ended March 31, 2026. For Q4 FY26, the company reported revenue from operations of ₹456.6 crore, a decrease of 9% year-on-year, attributed to subdued demand impacted by macroeconomic uncertainties, rising input costs, and stable realization.
EBITDA for the quarter stood at ₹26.2 crore, a decline of 59% from ₹64.6 crore in the corresponding quarter of the previous year, with EBITDA margins at 5.7% compared to 12.9% in Q4 FY25. Net profit for Q4 FY26 was ₹19.5 crore, down 42% from ₹34.0 crore in Q4 FY25.
For the full financial year 2026 (FY26), revenue from operations increased by 4% year-on-year to ₹2,091.8 crore, compared to ₹2,003.9 crore in FY25. EBITDA for FY26 grew by 27% year-on-year to ₹228.7 crore, up from ₹180.3 crore in the previous year, with EBITDA margins improving to 10.9% from 9.0%.
The Crop Protection segment constituted approximately 78% of the company's revenue in FY26, with revenue at ₹1,631.2 crore and EBITDA at ₹243.6 crore, achieving an EBITDA margin of 14.9% and a capacity utilization of 72%. The Pigments segment contributed about 22% of the revenue, amounting to ₹460.6 crore with an EBITDA of ₹15.00 crore and an EBITDA margin of 3.3%, operating at 40% capacity utilization.
Mr. Ankit Patel, Chairman & Managing Director, commented that while the financial year began positively, export volumes faced pressure in the second half of FY26 due to macroeconomic uncertainties, including US tariffs and geopolitical headwinds, which also increased input costs. The company has strengthened its Crop Nutrition segment by adding three new nano fertilizer products (Nano DAP, Nano NPK, and Nano Zinc) to be manufactured at its Sanand facility without additional capital expenditure.
Operations in Titanium Dioxide (TiO2) have been temporarily suspended due to commercial unviability stemming from elevated raw material costs and weaker price realizations after the withdrawal of anti-dumping duty.
What to do with a filing like this
Meghmani Organics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Meghmani Organics Limited. Read the original for the full detail.